JonathanBarratt University of Leicester, Leicester, UKUnited Kingdom

JonathanBarratt
My research is focussed on a bench to bedside approach to improving our understanding of the pathogenesis of IgA nephropathy a common global cause of kidney failure. I am the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and Convener of the International IgA Nephropathy Network. I work closely with pharmaceutical companies interested in new treatments for IgA nephropathy, and am Chief Investigator for a number of international randomised controlled Phase 2 and 3 clinical trials in IgA nephropathy. I was a member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group. I am an Editorial Board member for Kidney International and the American Society of Nephrology journals. I am a co-Chair of the UK Glomerulonephritis Clinical Study Group and am the IgA nephropathy lead for the KDIGO Clinical Practice Guidelines for Glomerular Diseases.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/8481717143cd0a5cd1a8500e7c7d7498.png
First Name
Jonathan
Last Name
Barratt
Institution
Country.
United Kingdom

Friday, February 7, 2025

Time Session
2:15 p.m.
3:45 p.m.
JonathanBarratt Chair University of Leicester, Leicester, UKUnited Kingdom
SradhaKotwal Chair skotwal@georgeinstitute.org.auThe George Institute for Global HealthAustralia
TukaramJamale Chair tukaramjamale@yahoo.co.inProfessor and Head, Department of Nephrology, Seth GS Medical College and KEM Hospital, Mumbai IndiaIndia
  • New Innovations and Best Practices for Rare Kidney Disease
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • How Can the CureGN Help Us Better Understand Rare Kidney Disease?
    LauraMariani Speaker University of MichiganUnited States
  • Insights From Rare Kidney Disease Registries on Living With RKDs
    DanielGale Speaker United Kingdom
  • Living With Rare Kidney Disease in Africa: Experiences and Challenges
    IfeomaUlasi Speaker ifeoma.ulasi@unn.edu.ngCollege of Medicine, University of NigeriaNigeria
  • Q&A
Kumudini Hall 301

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
PierreRonco Chair Hôpital TenonFrance
RajkumarSharma Chair rksnepho206@gmail.comIndia
  • Glomerular Disease Diagnostics
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Advances in Glomerular Disease Treatment
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Evaluating Kidney Allograft Dysfunction
    SumitMohan Speaker Columbia UniversityUnited States
  • Prioritizing Patient-friendly Dialysis
    EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom
  • Risk Prediction in AKI and CKD
    NavdeepTangri Speaker United States
  • Q&A
Auditorium Brahmkamal Hall

Sunday, February 9, 2025

Time Session
9:45 a.m.
11:15 a.m.
DavidWheeler Chair University College LondonUnited Kingdom
  • What Have We Learned From CONVINCE?
    PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlUniversity Medical Center UtrechtNetherlands
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    PriscillaSmith Oral Abstract Presenter priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Auditorium Brahmkamal Hall

Thursday, February 6, 2025

Time Session
11:30 a.m.
1:30 p.m.
AdrianLiew Chair Mount Elizabeth Novena Hospital, SingaporeSingapore
SuceenaAlexander Chair Christian Medical College VelloreIndia
  • Approach to Nephritic Syndrome
    AdrianLiew Speaker Mount Elizabeth Novena Hospital, SingaporeSingapore
  • Case Presentation and Discussion 3
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Case Presentation and Discussion 4
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Case Presentation and Discussion 5
    SuceenaAlexander Speaker Christian Medical College VelloreIndia
Gulmohar Hall 302